Report cover image

Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease: Opportunity Assessment and Forecast

Publisher GlobalData
Published Nov 24, 2025
Length 82 Pages
SKU # GBDT20638218

Description

Hyperparathyroidism, Hyperphosphatemia, and Hyperkalemia in Chronic Kidney Disease: Opportunity Assessment and Forecast

Summary

This report covers the 7MM (US, 5EU, Japan) and provides an Excel-based forecast model for the CKD-HPT, HP and HK market through 2034.
  • There will be an overall increase in the diagnosed prevalent cases of CKD- HPT, HP and HK in the 7MM across the forecast period.
  • Across the 7MM, the mainstay treatment for HPT, HP, and HK involves phosphate binders, calcimimetics, and potassium binders
  • Significant clinical and environmental unmet needs remain in the CKD- HPT, HP and HK market.
  • The Combined sales for CKD-HPT, HP, and HK are expected to grow modestly over the forecast period, from $2.6 billion in 2024 to $4.0 billion by 2034, at a compound annual growth rate (CAGR) of 4.4%.
Scope
  • Overview of CKD, including epidemiology, symptoms, diagnosis, and disease management.
  • Annualized CKD- HPT, HP and HK therapeutics market revenue in 7MM (US, 5EU, and Japan), annual cost of therapy and treatment usage pattern in 2024 and forecast for 10 years to 2034.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the CKD- HPT, HP and HK therapeutics market.
  • Pipeline analysis, comprehensive data assessing emerging trends and mechanisms of action under development for CKD- HPT, HP and HK treatment. The most promising candidates in late-stage development are profiled.
  • Analysis of the current and future market competition in the 7MM CKD- HPT, HP and HK therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the CKD- HPT, HP and HK therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the CKD- HPT, HP and HK therapeutics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Please note: this is delivered as a zip file.

Table of Contents

82 Pages
1. Preface
1.1. Contents
1.2. Abbreviations
1.3. Related Reports
2. Executive Summary
3. Disease Overview
3.1. Overview of CKD
3.2. Classification of CKD
3.3. Etiology & Pathophysiology of CKD-HPT, HP, and HK
3.4. CKD- HPT, HP, and HK SWOT Analysis
4. Epidemiology
4.1. Diagnosed Prevalent Cases of CKD
4.2. Age-Specific Trends in Diagnosed Prevalent Cases of CKD
4.3. Sex-Specific Diagnosed Prevalent Cases of CKD
4.4. Diagnosed Prevalent Cases of CKD Based on Dialysis Dependence
4.5. Diagnosed Prevalent Cases of CKD with HPT
4.6. Diagnosed Prevalent Cases of CKD with HP
4.7. Diagnosed Prevalent Cases of CKD with HK
4.8. Total Prevalent Cases of CKD
4.9. Total Prevalent Cases of CKD by Stage
4.10. Sources and Methodology: Total Prevalent Cases of CKD by Stage
4.11. Sources and Methodology: Diagnosed Prevalent Cases of CKD
4.12. Sources and Methodology: Diagnosed Prevalent Cases of CKD by Stage
4.13. Sources and Methodology: Diagnosed Prevalent Cases of CKD Based on Dialysis Dependence
4.14. Sources and Methodology: Diagnosed Prevalent Cases of CKD with HPT, HP, and HK Among Dialysis-Dependent and Non-dialysis-Dependent CKD Cases
4.15. Sources and Methodology: Total Prevalent Cases of CKD
4.16. Sources and Methodology - Diagnosed Prevalent Cases of CKD with HPT Among Dialysis-Dependent and Non-Dialysis-Dependent CKD Cases
4.17. Sources and Methodology - Diagnosed Prevalent Cases of CKD with HP Among Dialysis-Dependent and Non-dialysis-Dependent CKD Cases
4.18. Sources and Methodology - Diagnosed Prevalent Cases of CKD with HK Among Dialysis-Dependent and Non-Dialysis-Dependent CKD Cases
5. Current Treatment Options
5.1. Treatment Paradigm
5.2. Current Treatment Options
5.3. Product Profile: sevelamer carbonate/sevelamer hydrochloride
5.4. Product Profile: lanthanum carbonate
5.5. Product Profile: Velphoro (sucroferric oxyhydroxide)
5.6. Product Profile: Auryxia (ferric citrate)
5.7. Product Profile: cinacalcet
5.8. Product Profile: Auryxia (ferric citrate)
5.9. Product Profile: Parsabiv (etelcalcetide hydrochloride)
5.10. Product Profile: Orkedia (evocalcet)
5.11. Product Profile: Rayaldee (calcifediol ER)
5.12. Product Profile: Veltassa (patiromer sorbitex calcium)
5.13. Product Profile: Lokelma (sodium zirconium cyclosilicate)
5.14. Product Profile: Xphozah/Phozevel (tenapanor hydrochloride)
6. Unmet Needs and Opportunities
6.1. Unmet Needs in CKD- HPT, HP, and HK
6.2. Poor Medication Adherence and High Pill Burden
6.3. Drug Cost and Market Access
6.4. Improving Tolerability and Side-Effect Profile
6.5. Optimal Management of HK Treatments
7. R&D Strategies
7.1. Trends in Clinical Trial Design for CKD- HPT, HP, and HK
7.2. Trends in Deal-Making in CKD- HPT, HP, and HK
8. Pipeline Assessment
8.1. CKD- HPT, HP, and HK Pipeline Overview
8.2. Late-Stage Pipeline Agents for CKD- HPT, HP, and HK
8.3. Product Profile: upacicalcet sodium
8.4. Product Profile: AP-301
8.5. Product Profile: TS-172
8.6. CKD- HPT, HP, and HK Clinical Trials (Phase II/III) Overview
9. Market Outlook
9.1. CKD- HPT, HP, and HK Market Outlook
9.2. CKD- HPT, HP, and HK Market Forecast
9.3. Market Drivers and Barriers
10. Appendix
10.1. Primary Research - KOL Information
10.2. About the Authors
11. Contact Us

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us